Apixaban in Subjects With Peritoneal Dialysis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 8, 2019

Primary Completion Date

December 10, 2022

Study Completion Date

December 10, 2022

Conditions

Chronic Renal InsufficiencyPeritoneal Dialysis

Interventions

DRUG

Apixaban Oral

one Tablet 5mg

Trial Locations (1)

CHU Caen, Caen

All Listed Sponsors

collaborator

University Hospital, Rouen

OTHER

lead

University Hospital, Caen

OTHER

NCT04006093 - Apixaban in Subjects With Peritoneal Dialysis | Biotech Hunter | Biotech Hunter